Immune reconstitution following allogeneic peripheral blood progenitor cell transplantation:: Comparison of recipients of positive CD34+ selected grafts with recipients of unmanipulated grafts

We compared the kinetic recovery of lymphocytes and their subsets in two groups of patients submitted to allogeneic peripheral blood progenitor cell transplantation (allo-PBT): those receiving lymphocyte-depleted leukaphereses by positive selection of CD34(+) cells (group 1, n = 18) and those receiving unmanipulated leukaphereses (group 2, n = 15). Patients were conditioned with cyclophosphamide (120 mg/kg) and fractioned total body irradiation (13 Gy, group 1; 12 Gy, group 2). The mean number (x10(6)/kg) of CD34(+) and CD3(+) cells infused was 4.0 and 0.67, respectively, in group 1 patients, and 4.7 and 274, respectively, for group 2 patients. Graft-versus-host disease prophylaxis consisted of cyclosporin A + methylprednisolone for group I and cyclosporin A + methotrexate for group 2. Median follow-up was 7 months (range 2-8 months) for both groups. During the first 6 months post-transplant, CD4(+) cell counts were lower in group 1 as compared with group 2 (p = 0.014, 0.010, 0.011, 0.0003, and 0.052 at 0.5, 1, 2, 3, and 6 months, respectively), whereas there was no difference at 8 months. The number of CD4(+)CD45RA(+) cells was very low throughout the study in both groups, being lower in group 1 than in group 2, especially during the first 3 months posttransplant (p = 0.007 and 0.0006 at 1 and 3 months). Normal levels of CD8(+) cells were reached by 1 month post-transplant in both groups. TCR gamma delta(+) cell counts were lower in group 1 than in group 2 during the first 4 months post-transplant (p = 0.001, 0.004, and 0.04 at 1, 3, and 4 months). A normal number of natural killer cells (CD3(-)CD56(+)) was achieved 1 month posttransplant in both groups. B lymphocytes (CD19(+)) showed low or undetectable counts throughout the first 4 months in both groups, achieving the normal range at 8 months. These results show that, during the first 6 months-following allo-PBT with CD34(+) selected grafts, the number of CD4(+), CD4(+)CD45RA(+), and TCR gamma delta(+) cells is significantly lower than after unmanipulated allo-PBT; these differences disappeared at 8 months. In contrast, there are no differences between transplant groups in the recovery of CD8(+), CD19(+), and natural killer cells. (C) 1999 International Society for Experimental Hematology. Published by Elsevier Science Inc.